{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T18:10:23Z","timestamp":1733249423543,"version":"3.30.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00105-024-05431-7","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T09:54:05Z","timestamp":1732787645000},"page":"913-923","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Durch Genmutationen entstehende und zu fragiler Haut bei Kindern f\u00fchrende Erbkrankheiten","Genetic diseases with skin fragility in children"],"prefix":"10.1007","volume":"75","author":[{"given":"Stella","family":"Gewert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Trefzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"key":"5431_CR1","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/jdv.18554","volume":"37","author":"E Bourrat","year":"2023","unstructured":"Bourrat\u00a0E, Taieb\u00a0C, Marqui\u00e9\u00a0A et\u00a0al (2023) Burden of caregivers and out-of-pocket expenditures related to epidermolysis bullosa in France. J\u00a0Eur Acad Dermatol Venereol JEADV 37:194\u2013203. https:\/\/doi.org\/10.1111\/jdv.18554","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"key":"5431_CR2","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jaad.2009.03.052","volume":"61","author":"J-D Fine","year":"2009","unstructured":"Fine\u00a0J\u2011D, Mellerio\u00a0JE (2009) Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part I. Epithelial associated tissues. J\u00a0Am Acad Dermatol 61:367\u2013384. https:\/\/doi.org\/10.1016\/j.jaad.2009.03.052 (quiz 385\u2013386)","journal-title":"J Am Acad Dermatol"},{"key":"5431_CR3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jaad.2009.03.053","volume":"61","author":"J-D Fine","year":"2009","unstructured":"Fine\u00a0J\u2011D, Mellerio\u00a0JE (2009) Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part II. Other organs. J\u00a0Am Acad Dermatol 61:387\u2013402. https:\/\/doi.org\/10.1016\/j.jaad.2009.03.053 (quiz 403\u2013404)","journal-title":"J Am Acad Dermatol"},{"key":"5431_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.20096","author":"L Frommherz","year":"2024","unstructured":"Frommherz\u00a0L, Giehl\u00a0K, Hofmann\u00a0J et\u00a0al (2024) Epidermolytic ichthyosis: Clinical spectrum and burden of disease in a\u00a0large German cohort. J\u00a0Eur Acad Dermatol Venereol JEADV. https:\/\/doi.org\/10.1111\/jdv.20096","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"key":"5431_CR5","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/ddg.15416","volume":"22","author":"S Gewert","year":"2024","unstructured":"Gewert\u00a0S, Davidovic\u00a0M, Has\u00a0C, Kiritsi\u00a0D (2024) Dupilumab improves itch and blistering in different subtypes of epidermolysis bullosa. J\u00a0Dtsch Dermatol Ges J Ger Soc Dermatol JDDG 22:1139\u20131144. https:\/\/doi.org\/10.1111\/ddg.15416","journal-title":"J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG"},{"key":"5431_CR6","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.jid.2018.05.020","volume":"138","author":"C Has","year":"2018","unstructured":"Has\u00a0C (2018) Peeling Skin Disorders: A\u00a0Paradigm for Skin Desquamation. J\u00a0Invest Dermatol 138:1689\u20131691. https:\/\/doi.org\/10.1016\/j.jid.2018.05.020","journal-title":"J Invest Dermatol"},{"key":"5431_CR7","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/bjd.18921","volume":"183","author":"C Has","year":"2020","unstructured":"Has\u00a0C, Bauer\u00a0JW, Bodemer\u00a0C et\u00a0al (2020) Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. Br J Dermatol 183:614\u2013627. https:\/\/doi.org\/10.1111\/bjd.18921","journal-title":"Br J Dermatol"},{"key":"5431_CR8","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/jdv.18637","volume":"37","author":"C Has","year":"2023","unstructured":"Has\u00a0C, Hess\u00a0M, Anem\u00fcller\u00a0W et\u00a0al (2023) Epidemiology of inherited epidermolysis bullosa in Germany. J\u00a0Eur Acad Dermatol Venereol JEADV 37:402\u2013410. https:\/\/doi.org\/10.1111\/jdv.18637","journal-title":"J Eur Acad Dermatol Venereol JEADV"},{"key":"5431_CR9","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/bjd.18128","volume":"182","author":"C Has","year":"2020","unstructured":"Has\u00a0C, Liu\u00a0L, Bolling\u00a0MC et\u00a0al (2020) Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosa. Br J Dermatol 182:574\u2013592. https:\/\/doi.org\/10.1111\/bjd.18128","journal-title":"Br J Dermatol"},{"key":"5431_CR10","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2147\/TCRM.S386923","volume":"19","author":"P-C Hou","year":"2023","unstructured":"Hou\u00a0P\u2011C, Del Agua\u00a0N, Lwin\u00a0SM et\u00a0al (2023) Innovations in the Treatment of Dystrophic Epidermolysis Bullosa (DEB): Current Landscape and Prospects. Ther Clin Risk Manag 19:455\u2013473. https:\/\/doi.org\/10.2147\/TCRM.S386923","journal-title":"Ther Clin Risk Manag"},{"key":"5431_CR11","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.jid.2018.09.038","volume":"139","author":"JH Kim","year":"2019","unstructured":"Kim\u00a0JH, Kim\u00a0S\u2011E, Park\u00a0HS et\u00a0al (2019) A Homozygous Nonsense Mutation in the DSG3 Gene Causes Acantholytic Blisters in the Oral and Laryngeal Mucosa. J\u00a0Invest Dermatol 139:1187\u20131190. https:\/\/doi.org\/10.1016\/j.jid.2018.09.038","journal-title":"J Invest Dermatol"},{"key":"5431_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ajmg.c.31552","volume":"175","author":"F Malfait","year":"2017","unstructured":"Malfait\u00a0F, Francomano\u00a0C, Byers\u00a0P et\u00a0al (2017) The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet 175:8\u201326. https:\/\/doi.org\/10.1002\/ajmg.c.31552","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"5431_CR13","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.jid.2023.10.030","volume":"144","author":"EA O\u2019Toole","year":"2024","unstructured":"O\u2019Toole\u00a0EA, Kelsell\u00a0DP, Caterina\u00a0MJ et\u00a0al (2024) Pachyonychia Congenita: A\u00a0Research Agenda Leading to New Therapeutic Approaches. J\u00a0Invest Dermatol 144:748\u2013754. https:\/\/doi.org\/10.1016\/j.jid.2023.10.030","journal-title":"J Invest Dermatol"},{"key":"5431_CR14","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1056\/NEJMe2213203","volume":"387","author":"AS Payne","year":"2022","unstructured":"Payne\u00a0AS (2022) Topical Gene Therapy for Epidermolysis Bullosa. N\u00a0Engl J Med 387:2281\u20132284. https:\/\/doi.org\/10.1056\/NEJMe2213203","journal-title":"N Engl J Med"},{"key":"5431_CR15","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00105-019-4433-5","volume":"70","author":"A Reimer","year":"2019","unstructured":"Reimer\u00a0A, Has\u00a0C (2019) Syndrome mit Hautfragilit\u00e4t. Hautarzt 70:481\u2013489. https:\/\/doi.org\/10.1007\/s00105-019-4433-5","journal-title":"Hautarzt"},{"key":"5431_CR16","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1182\/blood.V92.11.4053","volume":"92","author":"I Tezcan","year":"1998","unstructured":"Tezcan\u00a0I, Xu\u00a0W, Gurgey\u00a0A et\u00a0al (1998) Congenital erythropoietic porphyria successfully treated by allogeneic bone marrow transplantation. Blood 92:4053\u20134058","journal-title":"Blood"},{"key":"5431_CR17","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1001\/jamadermatol.2022.2885","volume":"158","author":"L Trefzer","year":"2022","unstructured":"Trefzer\u00a0L, Schwieger-Briel\u00a0A, Nystr\u00f6m\u00a0A et\u00a0al (2022) Kidney-Urinary Tract Involvement in Intermediate Junctional Epidermolysis Bullosa. JAMA Dermatol 158:1057\u20131062. https:\/\/doi.org\/10.1001\/jamadermatol.2022.2885","journal-title":"JAMA Dermatol"},{"key":"5431_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.matbio.2018.11.006","volume":"81","author":"H Vahidnezhad","year":"2019","unstructured":"Vahidnezhad\u00a0H, Youssefian\u00a0L, Saeidian\u00a0AH et\u00a0al (2019) Mutations in PLOD3, encoding lysyl hydroxylase 3, cause a\u00a0complex connective tissue disorder including recessive dystrophic epidermolysis bullosa-like blistering phenotype with abnormal anchoring fibrils and type\u00a0VII collagen deficiency. Matrix Biol J Int Soc Matrix Biol 81:91\u2013106. https:\/\/doi.org\/10.1016\/j.matbio.2018.11.006","journal-title":"Matrix Biol J Int Soc Matrix Biol"},{"key":"5431_CR19","unstructured":"https:\/\/www.namse.de\/zum-aktionsbuendnis\/aktivitaeten-und-entwicklungen-im-zeitverlauf;. Zugegriffen: 28. Aug. 2024"},{"key":"5431_CR20","unstructured":"https:\/\/www.vdek.com\/magazin\/ausgaben\/2021-02\/ein-buendnis-fuer-die-seltenen.html. Zugegriffen: 28. Aug. 2024"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-024-05431-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-024-05431-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-024-05431-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T17:04:31Z","timestamp":1733245471000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-024-05431-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["5431"],"URL":"https:\/\/doi.org\/10.1007\/s00105-024-05431-7","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"type":"print","value":"2731-7005"},{"type":"electronic","value":"2731-7013"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"assertion":[{"value":"16 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"L. Trefzer ist Stipendiatin des Berta-Ottenstein-Programms f\u00fcr Clinician Scientists der Universit\u00e4t Freiburg. Sie erhielt F\u00f6rdermittel von der Deutschen Stiftung Kinderdermatologie zur Unterst\u00fctzung ihrer Arbeit in der Kinderdermatologie. Sie erhielt Kongress- und Vortragshonorare von Sun Pharma, Lilly GmbH Deutschland, dem Psoriasis Netzwerk Deutschland und Sanofi Regeneron. S.\u00a0Gewert gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autorinnen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}